These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10714428)

  • 1. Is inhaled beclomethasone (BDP) with a non-CFC propellant equivalent to the CFC propellant formulations?
    Chrystyn H
    Respir Med; 2000 Feb; 94(2):177-9; author reply 179-80. PubMed ID: 10714428
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma (Respir Med 1999; 93: 245-251).
    Pavord ID
    Respir Med; 2000 Feb; 94(2):182-3; author reply 183. PubMed ID: 10714431
    [No Abstract]   [Full Text] [Related]  

  • 3. Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone.
    Lipworth BJ; Jackson CM
    Respir Med; 2000 Feb; 94(2):177; author reply 179-80. PubMed ID: 10714427
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: inhaled beclomethassone (BDP) with non-CFC propellent (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma (Respir Med 19999; 93:245-251).
    Zanen P
    Respir Med; 2000 Feb; 94(2):180-1. PubMed ID: 10714429
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA-134a) is equivalent to BDP-CFC for the treatment of asthma: Milanowski et al. (Respir Med 1999; 93: 245-251).
    Ayres JG
    Respir Med; 2000 Feb; 94(2):181-2; author reply 183. PubMed ID: 10714430
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
    Milanowski J; Qualtrough J; Perrin VL
    Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metered-dose inhaler formulations with beclomethasone-17,21-dipropionate using the ozone friendly propellant R 134a.
    Steckel H; Müller BW
    Eur J Pharm Biopharm; 1998 Jul; 46(1):77-83. PubMed ID: 9700025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R; Ringdal N; Ward SM; Stampone P; Donnell D
    Br J Clin Pract; 1997; 51(1):11-5. PubMed ID: 9158265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local versus total systemic bioavailability of beclomethasone dipropionate CFC and HFA metered dose inhaler formulations.
    Harrison LI
    J Aerosol Med; 2002; 15(4):401-6. PubMed ID: 12581506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
    Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L
    Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
    Davies RJ; Stampone P; O'Connor BJ
    Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
    Pedersen S; Warner J; Wahn U; Staab D; Le Bourgeois M; Van Essen-Zandvliet E; Arora S; Szefler SJ;
    Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
    J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
    Szefler SJ; Warner J; Staab D; Wahn U; Le Bourgeois M; van Essen-Zandvliet EE; Arora S; Pedersen S;
    J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulite technology: pharmacodynamic and pharmacokinetic implications.
    Woodcock A; Acerbi D; Poli G
    Respir Med; 2002 Aug; 96 Suppl D():S9-15. PubMed ID: 12201080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C; Guerriero M; Tognella S; Dal Negro RW
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD; Walters EG
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
    Busse WW; Brazinsky S; Jacobson K; Stricker W; Schmitt K; Vanden Burgt J; Donnell D; Hannon S; Colice GL
    J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.